Higher Inflammation From Early Adulthood Linked to Worse Cognition
By Elana Gotkine HealthDay Reporter
MONDAY, July 8, 2024 -- Worse midlife executive function and processing speed are seen with consistently higher or moderate/increasing inflammation starting in early adulthood, according to a study published online July 3 in Neurology.
Amber L. Bahorik, Ph.D., from the University of California in San Francisco, and colleagues used data from the Coronary Artery Risk Development in Young Adults study to identify inflammation trajectories (C-reactive protein [CRP] levels <10 mg/L) over 18 years through early adulthood (age, 24 to 58 years). Six cognitive domains were assessed, with the primary outcome of poor cognitive performance, defined as a decline of at least one standard deviation than the mean on each domain. Data were included for 2,364 participants (mean age, 50.2 years).
During 18 years, there were three CPR trajectories: low stable, moderate/increasing, and consistently higher (45, 16, and 39 percent, respectively). The researchers found that consistently higher and moderate/increasing CRP levels were associated with higher odds of poor processing speed compared with lower stable CRP; in addition, higher odds of poor executive function were seen in association with consistently higher CRP. No associations were seen for moderate/increasing and consistently higher CRP with memory, letter fluency, category fluency, or global cognition.
"Our results indicate that higher or increasing inflammation trajectories may be associated with (or influence) higher odds of poor cognitive function at midlife," the authors write.
One author disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-09 01:15
Read more
- Arrowhead Pharmaceuticals Presents New Data at AHA24 from PALISADE Phase 3 Study and Open-Label Extension from MUIR and SHASTA-2 Studies of Plozasiran
- More Than One-Third Have ED Visit Within 90 Days Before Cancer Diagnosis
- Malaria Developing Resistance to Drug That Saves Children's Lives
- AHA: AI Analysis of Images, Videos Can ID Early Hypertension, Diabetes
- Light Physical Activity Linked to Improved Vascular Parameters in RA
- Overtreatment Common for Older Men With Prostate Cancer
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions